Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Trius Therapeutics Inc (TSRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/13/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 EASTHAM KARIN (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 6,000 shares @ $0
Disposed/sold 12,114 shares @ $0
Disposed/sold 17,441 options to buy @ $7.57, valued at $132k
Disposed/sold 6,000 options to buy @ $3.5, valued at $21k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 O'Leary Brendan (Director) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 Schmid John P. (CFO) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 TRUEX PAUL F (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 11,270 shares @ $0
Disposed/sold 12,403 options to buy @ $1.29, valued at $16k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 MORNEAU MICHAEL (VP Finance & CAO) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 Stein Jeffrey (President & CEO) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 210,457 shares @ $0
Disposed/sold 81,280 options to buy @ $0.52, valued at $42.3k
Disposed/sold 156,976 options to buy @ $1.29, valued at $202.5k
Disposed/sold 30,813 options to buy @ $1.29, valued at $39.7k
Disposed/sold 200,000 options to buy @ $3.5, valued at $700k
Disposed/sold 250,000 options to buy @ $4.8, valued at $1.2M
Disposed/sold 275,000 options to buy @ $6.13, valued at $1.7M
09/13/2013 4 KABAKOFF DAVID S (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 5,285 shares @ $0
Disposed/sold 106,081 shares @ $0
Disposed/sold 18,000 options to buy @ $3.5, valued at $63k
Disposed/sold 18,000 options to buy @ $8.26, valued at $148.7k
Disposed/sold 18,000 options to buy @ $5.05, valued at $90.9k
Disposed/sold 21,000 options to buy @ $7.77, valued at $163.2k
09/13/2013 4 Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 100,000 options to buy @ $7.67, valued at $767k
09/13/2013 4 Fischer Seth H.Z. (Director) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 ATWOOD BRIAN G (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 9,302 options to buy @ $1.29, valued at $12k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 Kjellson Nina S (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 9,302 options to buy @ $1.29, valued at $12k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 Schroeder Theodore R (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 15,116 options to buy @ $7.57, valued at $114.4k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
07/23/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
07/16/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 3,500 shares @ $10.55, valued at $36.9k
07/12/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 1,000 shares @ $8.58, valued at $8.6k
Sold 500 shares @ $9.32, valued at $4.7k
Sold 5,000 shares @ $10.1, valued at $50.5k
07/12/2013 4 MORNEAU MICHAEL (VP Finance & CAO) has filed a Form 4 on Trius Therapeutics Inc
07/01/2013 4 Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc
07/01/2013 4 Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc
06/12/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 3,000 shares @ $9.0833, valued at $27.2k
06/11/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 1,000 shares @ $8.94, valued at $8.9k
06/11/2013 4/A Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 3,000 shares @ $7.475, valued at $22.4k
06/04/2013 4 Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 2,000 shares @ $7.9, valued at $15.8k
06/03/2013 4 Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc
06/03/2013 4 Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc
Txns: Granted 100,000 options to buy @ $7.67, valued at $767k
06/03/2013 3 Form 3 - Initial statement of beneficial ownership of securities
05/28/2013 4 Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 12,000 shares @ $7.9266, valued at $95.1k
05/28/2013 4/A Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 12,000 shares @ $7.85, valued at $94.2k
05/28/2013 4 Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 12,000 shares @ $7.9266, valued at $95.1k
05/28/2013 4/A Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Sold 12,000 shares @ $7.65, valued at $91.8k
05/23/2013 4 Fischer Seth H.Z. (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Granted 2,500 options to buy @ $7.77, valued at $19.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy